Impact of type 2 diabetes on serial changes in tissue characteristics of coronary plaques: An integrated backscatter intravascular ultrasound analysis

European Heart Journal Cardiovascular Imaging

Volumn 13, Issue 9, 2012, Pages 717-723

  Inaba, Shinji ^a   Okayama, Hideki ^b   Funada, Jun Ichi ^c   Higashi, Haruhiko ^d   Saito, Makoto ^d   Yoshii, Toyofumi ^d   Hiasa, Go ^d   Sumimoto, Takumi ^d   Takata, Yasunori ^a   Nishimura, Kazuhisa ^a   Inoue, Katsuji ^a   Ogimoto, Akiyoshi ^a   Igaki, Jitsuo ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c National Hospital Organization Ehime Medical Center   (Japan)

^d Kitaishikai Hospital   (Japan)

Author keywords

Coronary artery disease; Integrated backscatter intravascular ultrasound; Lipid rich plaque; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY CATHETER; ARTICLE; BODY MASS; CARDIAC IMAGING; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE COURSE; FEMALE; GLYCEMIC CONTROL; HUMAN; IMAGE ANALYSIS; INTEGRATED BACKSCATTER INTRAVASCULAR ULTRASOUND; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SYSTOLIC BLOOD PRESSURE;

AGED; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PLAQUE, ATHEROSCLEROTIC; REPRODUCIBILITY OF RESULTS; RISK FACTORS; STATISTICS, NONPARAMETRIC; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84866261113     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jes033     Document Type: Article

References (27)

1. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007;115:114-26.
2. Action to Control Cardiovascular Risk in Diabetes Study Group. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59.
3. ADVANCE Collaborative Group. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72.
4. DuckworthW, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-39.
5. Meier M, Hummel M. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies. Vasc Health Risk Manag 2009;5:859-71.
6. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89.
7. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008;358:580-91.
8. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation 2004;110:1061-8.
9. Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D et al. CAMELOT Investigators. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004;292:2217-25.
10. Nissen SE, Nicholls SJ, Wolski K, Nesto R, Kupfer S, Perez A et al., PERISCOPE Investigators. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. JAMA 2008;299:1561-73.
11. Nicholls SJ, Tuzcu EM, Kalidindi S, Wolski K, Moon KW, Sipahi I et al. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol 2008;52: 255-62.
12. Mintz GS. Diabetic coronary artery disease: how little we know and how little intravascular ultrasound has taught us. J Am Coll Cardiol 2008;52:263-5.
13. Kawasaki M, Takatsu H, Noda T, Ito Y, Kunishima A, Arai M et al. Noninvasive quantitative tissue characterization and two-dimensional color-coded map of human atherosclerotic lesions using ultrasound integrated backscatter. J Am Coll Cardiol 2001;38:486-92.
14. Kawasaki M, Bouma BE, Bressner J, Houser SL, Nadkarni SK, MacNeill BD et al. Diagnostic accuracy of optical coherence tomography and integrated backscatter intravascular ultrasound images for tissue characterization of human coronary plaques. J Am Coll Cardiol 2006;48:81-8.
15. Inaba S, Okayama H, Funada J, Hashida H, Hiasa G, Sumimoto T et al. Relationship between smaller calcifications and lipid-rich plaques on integrated backscatterintravascular ultrasound. Int J Cardiol 2010;145:347-8.
16. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26:S5-20.
17. Kawasaki M, Sano K, Okubo M, Yokoyama H, Ito Y, Murata I et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2005;45:1946-53.
18. Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003;290:2292-300.
19. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
20. Virmani R, Burke AP, Kolodgie F. Morphological characteristics of coronary atherosclerosis in diabetes mellitus. Can J Cardiol 2006;22:81-4B.
21. Burke AP, Kolodgie FD, Zieske A, Fowler DR, Weber DK, Varghese PJ et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol 2004;24:1266-71.
22. Amano T, Matsubara T, Uetani T, Nanki M, Marui N, Kato M et al. Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance. J Am Coll Cardiol Img 2008;1:39-45.
23. Nasu K, Tsuchikane E, Katoh O, Fujita H, Surmely JF, Ehara M et al. Plaque characterization by virtual histology intravascular ultrasound analysis in patients with type 2 diabetes. Heart 2008;94:429-33.
24. Nicholls SJ, Hsu A, Wolski K, Hu B, Bayturan O, Lavoie A et al. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol 2010;55:2399-407.
25. Sano K, Kawasaki M, Ishihara Y, Okubo M, Tsuchiya K, Nishigaki K et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2006;47:734-41.
26. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R et al., American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203.
27. Mintz GS, Maehara A. Serial intravascular ultrasound assessment of atherosclerosis progression and regression. State-of-the-art and limitations. Circ J 2009;73: 1557-60.